¼¿ïƯº°½ÃÀÇ»çȸ¿Í À¯ÇѾçÇà(´ëÇ¥ÀÌ»ç »çÀå ÃÖ»óÈÄ, ±èÀ±¼·)ÀÌ °øµ¿À¸·Î Á¦Á¤ ½Ã»óÇÏ´Â 'Á¦42ȸ À¯ÇÑÀÇÇлó' ¿µ¿¹ÀÇ ´ë»ó ¼ö»óÀڷδ ¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø ½ÉÀå³»°ú ¹Ú´ö¿ì ±³¼ö¿Í ¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø È£Èí±â³»°ú °í¿øÁß ±³¼ö°¡ ¼±Á¤µÇ¾î »óÆÐ¿Í »ó±Ý 2000¸¸¿øÀ» °¢°¢ ¼ö»óÇß´Ù.
¼¿ïƯº°½ÃÀÇ»çȸ(ȸÀå ³ªÇö)´Â Áö³ 15ÀÏ ¼¿ï½Ã ÀÇ»çȸ°ü¿¡¼ ¿¸° ÀÇ»ç½Å¹® â°£ 49Áֳ⠱â³ä½Ä ¹× Á¦42ȸ À¯ÇÑÀÇÇлó ½Ã»ó½ÄÀ» °¡Á³´Ù.
¹Ú´ö¿ì ±³¼ö´Â ½ºÅÙÆ® ½Ã¼ú°ú °ü»óµ¿¸Æ¿ìȸ¼úÀ» ¹ÞÀº ´ÙÇ÷°ü ÁúȯÀÚµéÀÇ Àå±âÀûÀÎ ÀÓ»ó°æ°ú¸¦ ºñ±³ ºÐ¼®ÇÑ ³í¹®À» ¹ßÇ¥ÇØ ÁÖ¸ñÀ» ¹Þ¾ÒÀ¸¸ç ³í¹®ÀÌ ÇØ¿Ü ÇмúÁö 'Circulation'¿¡ °ÔÀçµÅ Çѱ¹ÀÇÇÐÀÇ ¿ì¼ö¼ºÀ» ³Î¸® ¾Ë¸° Á¡ÀÌ ÀÎÁ¤¹Þ¾Æ ¼ö»óÀÚ·Î ¼±Á¤µÆ´Ù.
³í¹® Á¦¸ñÀº 'Long-Term Mortality After Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Artery Disease'.
°í¿øÁß ±³¼ö´Â ´ÙÁ¦³»¼º°áÇÙ°ú ±¤¹üÀ§³»¼º°áÇ٠ȯÀÚ¿¡°Ô 2Â÷ °áÇؾàÁ¦¸¦ Åõ¿©ÇÏ°í Àû±ØÀûÀ¸·Î ÆóÀýÁ¦¼úÀ» ½ÃÇàÇϸé 60% ÀüÈÄÀÇ Ä¡·á¼º°ø·üÀ» 80%±îÁö Çâ»ó½Ãų ¼ö ÀÖÀ½À» Áõ¸íÇÏ´Â ³í¹®À» ¹ßÇ¥ÇØ ¿ª½Ã ´ë»ó ¼ö»óÀÚ·Î ¼±Á¤µÆ´Ù. ³í¹®Àº ÇØ¿Ü ÇмúÁö 'Clinical Infectious Diseases'¿¡ °ÔÀçµÆ´Ù.
³í¹® Á¦¸ñÀº 'Treatment Outcomes for HIV-Uninfected Patients with Multidrug-Resistant and Extensively Drug-Resistant Tuberculos'.
À¯ÇÑÀÇÇлóÀº ±¹³» ÀÇÇйßÀüÀ» À§ÇÑ °ßÀÎÂ÷Àû ¿ªÇÒÀ» ÇØ¿Â Ã˸ÅÁ¦·Î '¹Ì·¡ÀÇ ÀÇÇйßÀüÀ» À§ÇÑ Ãʼ®À» ¸¶·ÃÇÏ°í ÀÇÇÐÀÚµéÀÇ ¿¬±¸ÀÇ¿åÀ» °íÃëÇÏ°í Çѱ¹ÀÇÇÐÀÇ ¹Ì·¡ÁöÇâÀû ÁÂÇ¥¸¦ ¸¶·Ã'Çϱâ À§ÇØ1967³â¿¡ Á¦Á¤µÅ ¿ì¸®³ª¶ó¿¡¼ °¡Àå ¿À·¡µÈ ÀÇÇлóÀ¸·Î ±×°£ ¿ì¸® ÀÇÇа踦 ´ëÇ¥ÇÏ´Â 100¿© ¸íÀÌ ³Ñ´Â ¼ö»óÀÚ¸¦ ¹èÃâÇÏ´Â µî ±¹³» ÃÖ°í ±ÇÀ§ÀÇ ÀÇÇÐ Çмú½Ã»óÁ¦µµ·Î ÀÚ¸®¸Å±èÇÏ°í ÀÖ´Ù.